TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 6 | 12 | 14 | 12 | 57 | 140 | 40 |
| P | %wins | 100 | 100 | 50 | 100 | 100 | 100 | 92 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/28/07 18:27 | 2/28/07 | CERS | Cerus Corp | DE | Health | MdEq | Surgical & Medical Instrument | Dawson William J | CA | O | CFO | P | 109 | 5.43 | 2 | 20 | 28 | 92 | D | 19 | -54 | -4 | -35 | -13 | -9 | -3 | -6 | 7 | 5 | 28 | 12 | 26 | 16 |
2/9/05 18:34 | 2/8/05 | CERS | Cerus Corp | DE | Health | BioPrd | Biological Products, (No Diag | Dawson William J | CA | O | CFO | P | 97 | 3.88 | 0 | 25 | New | 25 | D | -46 | -6 | 90 | 50 | 21 | 10 | 16 | -2 | 5 | 18 | -1 | 11 | 88 | 264 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |